Prof. Jianwu Qin 秦建武
Chief Physician, Professor
Department of Thyroid and Head and Neck Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of thyroid tumors, laryngeal cancer, and salivary gland tumors.
Dr. Qin graduated from Henan Medical University in 1984 and studied in Japan. As Director of Thyroid and Head and Neck Surgery at Henan Cancer Hospital, Dr. Qin developed a new surgical technique for the thyroid upper pole, known as the "Qin approach." Dr. Qin has published over 20 papers, co-authored three books, and received three provincial scientific achievement awards.
Professional roles
- Vice Chair, Thyroid Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Thyroid Disease Branch, China Medical Promotion Association
- Standing Committee Member, Thyroid Surgery Physician Committee, Surgical Branch, Chinese Medical Doctor Association
- Chair, Thyroid Tumor Professional Committee, Henan Anti-Cancer Association
Name order: in Chinese the family name comes first (Qin Jianwu). Papers usually list the name as Jianwu Qin or Qin J.
Selected publications
36 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Death Discov, 2025 (senior author): USP25 attenuates the immunosuppressive tumor microenvironment via the deubiquitination of TAB2 in head and neck squamous cell carcinoma. PubMed 41326342
- Front Immunol, 2025 (senior author): Crosstalk between metabolic reprogramming and microbiota: implications for cancer progression and novel therapeutic opportunities. PubMed 40463381
- Oral Oncol, 2023 (senior author): Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer. PubMed 37690364
- Surg Today, 2023 (senior author): Preoperative prediction of central neck metastasis in patients with clinical T1-2N0 papillary thyroid carcinoma. PubMed 36202940
- Mol Cell Biochem, 2023 (senior author): PGC-1α participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function. PubMed 35713741
- Front Oncol, 2022 (senior author): Design of new drugs for medullary thyroid carcinoma. PubMed 36544713
- Endocrine, 2022 (senior author): Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer. PubMed 35389141
- Langenbecks Arch Surg, 2022 (senior author): Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer. PubMed 35146548
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion